These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 16438854

  • 1. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
    [Abstract] [Full Text] [Related]

  • 2. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I, Mateša N, Lukač J, Kusić Z.
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [Abstract] [Full Text] [Related]

  • 3. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 4. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD, Wang LJ, Yao HT, Li J, Ding W, Yan LP.
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [Abstract] [Full Text] [Related]

  • 5. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
    Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A.
    J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
    [Abstract] [Full Text] [Related]

  • 6. [The expression of galectin-3 in nodular thyroid goitre].
    Chen WJ, Yu MH, Xu Y, Shen J.
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):452-5. PubMed ID: 16831319
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
    Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G.
    Acta Cytol; 2006 Jun; 50(1):28-34. PubMed ID: 16514837
    [Abstract] [Full Text] [Related]

  • 8. Ultrasound Risk Assessment Combined with Molecular Markers of Galectin-3, c-MET, HBME-1 and CK19 for Diagnosis of Malignant and Benign Thyroid Nodules.
    Han RL, Wang J, Zhang FJ, Zhao N, Gao BL.
    Pathol Oncol Res; 2019 Jul; 25(3):1075-1081. PubMed ID: 30361909
    [Abstract] [Full Text] [Related]

  • 9. The significance of Galectin-3 expression in the immunocytochemical evaluation of thyroid fine needle aspiration cytology.
    Ersoz S, Sert H, Yandi M, Erem C, Mungan S, Ersoz HO, Cobanoglu U, Hacihasanoglu A.
    Pathol Oncol Res; 2008 Dec; 14(4):457-60. PubMed ID: 18415710
    [Abstract] [Full Text] [Related]

  • 10. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N, Samija I, Kusić Z.
    Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
    [Abstract] [Full Text] [Related]

  • 11. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S.
    Diagn Cytopathol; 2004 Dec; 31(6):392-6. PubMed ID: 15540177
    [Abstract] [Full Text] [Related]

  • 12. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF.
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [Abstract] [Full Text] [Related]

  • 13. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 14. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 15. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M, Kapila K, Verma K.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):376-80. PubMed ID: 17001889
    [Abstract] [Full Text] [Related]

  • 16. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
    Cui W, Lu X, Zheng S, Ma Y, Liu X, Zhang W.
    Clin Lab; 2012 Jul 01; 58(5-6):419-26. PubMed ID: 22783570
    [Abstract] [Full Text] [Related]

  • 17. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q, Cai C, Chen H.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug 01; 50(8):668-72. PubMed ID: 26696207
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.